Global Life Science Ventures logo

Global Life Science Ventures

Europe, Bayern, Germany, München

Description

Global Life Science Ventures is a swiss investment fund focusing exclusively on the life sciences sector.

Investor Profile

Global Life Science Ventures has backed more than 29 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 28% of its total and boasts 14 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series A (24%)
  • Series C (21%)
  • Series B (21%)
  • Series D (14%)
  • Series E (7%)
  • Series Unknown (7%)
  • Debt Financing (3%)
  • Series F (3%)

Country Focus

  • United States (31%)
  • Switzerland (21%)
  • Germany (17%)
  • The Netherlands (10%)
  • Denmark (10%)
  • Austria (3%)
  • Tunisia (3%)
  • France (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Genetics
  • Manufacturing
  • Medical Device
  • Therapeutics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Global Life Science Ventures frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 4
Easton Capital
North America, New York, United States, New York
Co-Investments: 4
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 5
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 6
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3

What are some of recent deals done by Global Life Science Ventures?

Binx Health

Boston, Massachusetts, United States

Binx Health is a healthcare technology company that makes testing more convenient and accessible to individuals.

Health CareHealth DiagnosticsMedical DeviceMobile
Series DJan 23, 2017
Amount Raised: $35,000,000
Binx Health

Boston, Massachusetts, United States

Binx Health is a healthcare technology company that makes testing more convenient and accessible to individuals.

Health CareHealth DiagnosticsMedical DeviceMobile
Series CJan 29, 2015
Amount Raised: $20,000,000
Santaris Pharma

Hørsholm, Hovedstaden, Denmark

Santaris Pharma is a biopharmaceutical company focused on the discovery and development of RNA-targeted therapies.

BiotechnologyGeneticsHealth CarePharmaceutical
Series UnknownJun 21, 2012
Amount Raised: $12,000,000
Action Pharma

Aarhus, Midtjylland, Denmark

Action Pharma develops pharmaceutical products and treatment concepts for cardiovascular, inflammatory and acquired metabolic diseases.

BiotechnologyHealth CarePharmaceutical
Series CJul 16, 2010
Amount Raised: $6,300,000
Coapt Systems

Palo Alto, California, United States

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

BiotechnologyCosmetic SurgeryManufacturingMarketing
Debt FinancingDec 29, 2009
Amount Raised: $3,720,000
Agendia

Amsterdam, Noord-Holland, The Netherlands

Agendia provides molecular diagnostics and personalized treatment plans for cancer patients.

BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedical
Series ESep 23, 2009
Amount Raised: $23,000,000
Santaris Pharma

Hørsholm, Hovedstaden, Denmark

Santaris Pharma is a biopharmaceutical company focused on the discovery and development of RNA-targeted therapies.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CDec 30, 2007
Amount Raised: $29,994,619
Agendia

Amsterdam, Noord-Holland, The Netherlands

Agendia provides molecular diagnostics and personalized treatment plans for cancer patients.

BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedical
Series DAug 28, 2007
Amount Raised: $34,000,000
Nitec Pharma AG

Reinach, Aargau, Switzerland

Nitec is a pharmaceutical company that commercializes and develops medicines to treat chronic inflammation and pain-related diseases.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series BMar 29, 2007
Amount Raised: $26,000,000
Coapt Systems

Palo Alto, California, United States

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

BiotechnologyCosmetic SurgeryManufacturingMarketing
Series EMar 29, 2007
Amount Raised: $22,600,000

Find More Investors Like Global Life Science Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Global Life Science Ventures | Pipeseed